| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.099 | 0.09 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |